fbpx Skip to main content

BioCommunique Article

President is expected to sign bill into law soon. Current deal removes 10 years of data exclusivities for biologics.

Congress Approves USMCA Trade Deal

  • 2020-01-17T18:40:00.000+0000
  • Washington DC
  • Author: Laure Fabrega

On January 16th, the Senate voted to approve the USMCA (H.R.5430, the United States-Mexico-Canada Agreement Implementation Act) by an 89-10 vote, after seven committees rushed to move the deal forward this week. Sen. Feinstein voted yes; Sen. Harris voted no. The Senate wanted to finish the deal before the President’s impeachment trial takes over the legislative agenda. The House approved the bill before the holidays by a 385-41 vote. The President is expected to sign the bill into law soon. Mexico passed the revised deal in December and Canada is expected to vote on it in the next few weeks.

Biocom had adopted a support position on the agreement and advocated for its passage. However, in December, Democrats and the Administration reached a new trade deal that removed the 10 years of data exclusivities for biologics (which would have lengthened exclusivities for Canada and Mexico from 8 and 5 years respectively). All three countries had accepted this policy, which Biocom was strongly in favor of. View our press release condemning this major change and the impact it could have on future trade agreements.